List of Excipients in API mifepristone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mifepristone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Danco Laboratories LLC | MIFEPREX | mifepristone | 64875-001 | CELLULOSE, MICROCRYSTALLINE | |
| Danco Laboratories LLC | MIFEPREX | mifepristone | 64875-001 | MAGNESIUM STEARATE | |
| Danco Laboratories LLC | MIFEPREX | mifepristone | 64875-001 | POVIDONE | |
| Danco Laboratories LLC | MIFEPREX | mifepristone | 64875-001 | SILICON DIOXIDE | |
| Danco Laboratories LLC | MIFEPREX | mifepristone | 64875-001 | STARCH, CORN | |
| Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | ALUMINUM OXIDE | |
| Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mifepristone
Detailed excipient profiles for mifepristone
Excipient focus: ALUMINUM OXIDE
mifepristone drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mifepristone drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
mifepristone drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
mifepristone drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE
mifepristone drug variants containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
mifepristone drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
mifepristone drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
mifepristone drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
mifepristone drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mifepristone drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
mifepristone drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
mifepristone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
mifepristone drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
mifepristone drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
mifepristone drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
mifepristone drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
mifepristone drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
mifepristone drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
mifepristone drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | mifepristone | 0591-4390 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
| Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
| >Company | >Ingredient | >NDC |
mifepristone drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| GenBioPro Inc | mifepristone | 43393-001 |
| Danco Laboratories LLC | mifepristone | 64875-001 |
| Evita Solutions LLC | mifepristone | 84670-014 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
